Zimmer Biomet Holdings (ZBH) Construction in Progress (2009 - 2014)
Zimmer Biomet Holdings' (ZBH) quarterly Construction in Progress came in at $94.7 million in Q3 2014, up 5.69% year-on-year from $89.6 million in Q3 2013, and up 12.2% quarter-over-quarter from $84.4 million in Q2 2014.
Zimmer Biomet Holdings (ZBH) Construction in Progress (2009 - 2014) Analysis & Trends
Zimmer Biomet Holdings' Construction in Progress history runs 6 years deep, the most recent figure standing at $94.7 million for Q3 2014.
- On a quarterly basis, Construction in Progress rose 5.69% year-over-year to $94.7 million in Q3 2014; TTM through Sep 2014 was $94.7 million, a 5.69% increase from a year earlier, with the FY2013 full-year figure at $58.2 million, down 50.59% from the prior year.
- Construction in Progress improved to $94.7 million in Q3 2014 per ZBH's latest filing, from $84.4 million in the prior quarter.
- Across five years, Construction in Progress topped out at $123.3 million in Q1 2013 and bottomed at $58.2 million in Q4 2013.
- The 5-year median for Construction in Progress is $78.7 million (2011), against an average of $80.5 million.
- Across the five-year window, Construction in Progress jumped 71.31% in 2012 and sank 50.59% in 2013, its largest moves.
- Year by year, Construction in Progress stood at $66.5 million in 2010, then rose by 14.89% to $76.4 million in 2011, then jumped by 54.19% to $117.8 million in 2012, then sank by 50.59% to $58.2 million in 2013, then jumped by 62.71% to $94.7 million in 2014.
- Per Business Quant, the three latest ZBH Construction in Progress figures stand at $94.7 million (Q3 2014), $84.4 million (Q2 2014), and $75.1 million (Q1 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 94.70 Mn |
| Jun 30, 2014 | 84.40 Mn |
| Mar 31, 2014 | 75.10 Mn |
| Dec 31, 2013 | 58.20 Mn |
| Sep 30, 2013 | 89.60 Mn |
| Jun 30, 2013 | 82.80 Mn |
| Mar 31, 2013 | 123.30 Mn |
| Dec 31, 2012 | 117.80 Mn |
| Sep 30, 2012 | 102.10 Mn |
| Jun 30, 2012 | 83.20 Mn |
| Mar 31, 2012 | 81.00 Mn |
| Dec 31, 2011 | 76.40 Mn |
| Sep 30, 2011 | 59.60 Mn |
| Jun 30, 2011 | 65.90 Mn |
| Mar 31, 2011 | 65.20 Mn |
| Dec 31, 2010 | 66.50 Mn |
| Sep 30, 2010 | 62.10 Mn |
| Jun 30, 2010 | 60.50 Mn |
| Dec 31, 2009 | 62.00 Mn |